Tempus ECG-Low EF vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your healthcare facility regularly performs 12-lead ECGs and you seek an AI-powered solution to analyze these existing recordings for signs of low left ventricular ejection fraction. This tool is ideal for integrating into established clinical diagnostic workflows to aid in the further evaluation of patients 40 years or older at risk of heart failure.
View Tempus ECG-Low EF →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your clinical practice emphasizes early, non-invasive screening for low ejection fraction during routine physical exams. This tool is best suited for clinicians utilizing Eko digital stethoscopes who require rapid, AI-driven insights from heart sound and ECG recordings at the point of care.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF integrates into existing 12-lead ECG workflows, which are standard in healthcare facilities, potentially making its adoption smoother as it leverages widely available equipment. Eko ELEFT requires integration with specific Eko digital stethoscopes, which could introduce an additional hardware barrier for some users, despite its rapid results.
Clinical Value
Eko Low Ejection Fraction Tool (ELEFT)While both are FDA-cleared for LVEF detection, Eko ELEFT's integration into routine physical exams via a digital stethoscope allows for early, non-invasive screening at the point of care. This proactive approach to identifying heart failure risk during standard patient encounters offers a distinct advantage for widespread early detection compared to Tempus ECG-Low EF, which analyzes standard ECGs for further evaluation.
Pricing & Value
TieBoth tools require contacting the vendor for pricing information, making it impossible to assess their relative cost-effectiveness or value proposition. Neither company provides transparent pricing details in the provided information or readily available online.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong foundational readiness for enterprise use. However, Eko ELEFT is explicitly positioned as part of the 'SENSORAu2122 Cardiac Early Detection Platform, an enterprise solution' and is cloud-based, suggesting a more comprehensive and scalable architecture designed for large healthcare systems.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)Eko ELEFT demonstrates greater innovation by integrating AI-powered LVEF detection with a digital stethoscope, enabling rapid (approximately 15-second) point-of-care screening that analyzes both ECG and heart sound recordings. This novel approach for early detection during routine physical exams is more innovative than Tempus ECG-Low EF's application of AI to standard 12-lead ECG analysis.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health provides a dedicated Help Center with user manuals and FAQs, along with an 'Eko Academy' app for educational content on auscultation skills, directly supporting product usage and clinician development. While Tempus offers a resource center with broader educational materials and a 'Clinical Assistant' with real-time representative access, Eko's support ecosystem appears more directly tailored to the specific tool and its associated clinical practice.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Tool Name | Tempus ECG-Low EF | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Tempus AI | Eko Health |
| Description | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. | FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Key Analysis Input | 12-lead ECG recordings | ECG and heart sound recordings |
| Target Patient Population | Patients 40 years or older at risk of heart failure | Not specified |
| Output | Binary output (Low LVEF Detected / Not Detected) | AI-powered low ejection fraction detection |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.